{"id":"https://openalex.org/W4399123767","doi":"https://doi.org/10.1158/2767-9764.c.7258266.v1","title":"Data from Efficacy and Safety of Atezolizumab and Bevacizumab in Appendiceal Adenocarcinoma","display_name":"Data from Efficacy and Safety of Atezolizumab and Bevacizumab in Appendiceal Adenocarcinoma","publication_year":2024,"publication_date":"2024-05-29","ids":{"openalex":"https://openalex.org/W4399123767","doi":"https://doi.org/10.1158/2767-9764.c.7258266.v1"},"language":"en","primary_location":{"id":"doi:10.1158/2767-9764.c.7258266.v1","doi":"https://doi.org/10.1158/2767-9764.c.7258266.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.c.7258266.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/2767-9764.c.7258266.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087864079","display_name":"Nicholas J. Hornstein","orcid":"https://orcid.org/0000-0003-2089-8236","observed_orcids":["https://orcid.org/0000-0003-2089-8236"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nicholas J. Hornstein","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2089-8236","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037693918","display_name":"Mohammad A. A. Zeineddine","orcid":"https://orcid.org/0000-0001-8075-765X","observed_orcids":["https://orcid.org/0000-0001-8075-765X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mohammad A. Zeineddine","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8075-765X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075521973","display_name":"Betul Beyza Gunes","orcid":"https://orcid.org/0009-0004-9686-1952","observed_orcids":["https://orcid.org/0009-0004-9686-1952"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Betul B. Gunes","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0004-9686-1952","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054184508","display_name":"Andrew Jared Pellatt","orcid":"https://orcid.org/0000-0002-0127-9790","observed_orcids":["https://orcid.org/0000-0002-0127-9790"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew J. Pellatt","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0127-9790","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080487639","display_name":"Mark Knafl","orcid":"https://orcid.org/0000-0002-3953-2173","observed_orcids":["https://orcid.org/0000-0002-3953-2173"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark Knafl","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3953-2173","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063503509","display_name":"Haifeng Zhu","orcid":"https://orcid.org/0000-0001-7315-4105","observed_orcids":["https://orcid.org/0000-0001-7315-4105","https://orcid.org/0000-0002-2500-3369","https://orcid.org/0000-0001-6401-6448"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Haifeng Zhu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7315-4105","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009153348","display_name":"Anneleis F. Willett","orcid":"https://orcid.org/0009-0007-7582-9840","observed_orcids":["https://orcid.org/0009-0007-7582-9840"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anneleis F. Willett","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0007-7582-9840","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064033799","display_name":"Abdelrahman M.G. Yousef","orcid":"https://orcid.org/0000-0001-7761-8149","observed_orcids":["https://orcid.org/0000-0001-7761-8149"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Abdelrahman Yousef","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7761-8149","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035273559","display_name":"Suyu Liu","orcid":"https://orcid.org/0000-0003-0126-2646","observed_orcids":["https://orcid.org/0000-0003-0126-2646"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Suyu Liu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0126-2646","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047086634","display_name":"Ryan Sun","orcid":"https://orcid.org/0000-0003-1176-1561","observed_orcids":["https://orcid.org/0000-0003-1176-1561"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ryan Sun","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1176-1561","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067102201","display_name":"P. Andrew Futreal","orcid":"https://orcid.org/0000-0001-8663-2671","observed_orcids":["https://orcid.org/0000-0001-8663-2671"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew Futreal","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8663-2671","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006246174","display_name":"Scott Eric Woodman","orcid":"https://orcid.org/0000-0002-1157-6991","observed_orcids":["https://orcid.org/0000-0002-1157-6991"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Scott E. Woodman","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1157-6991","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005089353","display_name":"Melissa W. Taggart","orcid":"https://orcid.org/0000-0002-7803-9904","observed_orcids":["https://orcid.org/0000-0002-7803-9904"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Melissa W. Taggart","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7803-9904","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003827387","display_name":"Michael James Overman","orcid":"https://orcid.org/0000-0001-5377-135X","observed_orcids":["https://orcid.org/0000-0001-5377-135X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael J. Overman","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5377-135X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012619170","display_name":"Daniel M. Halperin","orcid":"https://orcid.org/0000-0002-3113-930X","observed_orcids":["https://orcid.org/0000-0002-3113-930X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel M. Halperin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3113-930X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032970786","display_name":"Kanwal P. S. Raghav","orcid":"https://orcid.org/0000-0003-1311-4173","observed_orcids":["https://orcid.org/0000-0003-1311-4173"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kanwal P. Raghav","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1311-4173","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5007315039","display_name":"John Paul Shen","orcid":"https://orcid.org/0000-0003-4588-2775","observed_orcids":["https://orcid.org/0000-0003-4588-2775"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Paul Shen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4588-2775","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12064","display_name":"Intraperitoneal and Appendiceal Malignancies","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12064","display_name":"Intraperitoneal and Appendiceal Malignancies","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11473","display_name":"Appendicitis Diagnosis and Management","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/appendiceal-adenocarcinoma","display_name":"appendiceal adenocarcinoma","score":1.0},{"id":"https://openalex.org/keywords/atezolizumab","display_name":"atezolizumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":1.0},{"id":"https://openalex.org/keywords/vegf-inhibition","display_name":"VEGF inhibition","score":0.8379999995231628},{"id":"https://openalex.org/keywords/pd-l1-blockade","display_name":"PD-L1 blockade","score":0.9760000109672546},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7329999804496765},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7720000147819519},{"id":"https://openalex.org/keywords/disease-control-rate","display_name":"disease control rate","score":0.6660000085830688},{"id":"https://openalex.org/keywords/chemotherapy-comparison","display_name":"chemotherapy comparison","score":0.550000011920929},{"id":"https://openalex.org/keywords/rare-diseases","display_name":"rare diseases","score":0.4909999966621399}],"concepts":[{"id":"https://openalex.org/C2775949291","wikidata":"https://www.wikidata.org/wiki/Q20707748","display_name":"Atezolizumab","level":5,"score":0.9394775629043579},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.8825690746307373},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4302237927913666},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3690006136894226},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.329135000705719},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.1875409483909607},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.14773547649383545},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.08320653438568115},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.06553801894187927}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2767-9764.c.7258266.v1","doi":"https://doi.org/10.1158/2767-9764.c.7258266.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.c.7258266.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/2767-9764.c.7258266.v1","doi":"https://doi.org/10.1158/2767-9764.c.7258266.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.c.7258266.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.75,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4393216394","https://openalex.org/W4252058598","https://openalex.org/W4389074740","https://openalex.org/W4288703684","https://openalex.org/W2767978387","https://openalex.org/W2037317309","https://openalex.org/W2733092439","https://openalex.org/W2051540233","https://openalex.org/W2090201823","https://openalex.org/W2007136227"],"abstract_inverted_index":{"AbstractPurpose:":[0],"Appendiceal":[1],"adenocarcinoma":[2],"(AA)":[3],"remains":[4,177],"an":[5,178],"orphan":[6,179],"disease":[7,86,180],"with":[8,70,80,95,106,131,167,181],"limited":[9,182],"treatment":[10,163],"options":[11,185],"for":[12,37,135,165,186,192],"patients":[13,166,187],"unable":[14],"to":[15,121],"undergo":[16],"surgical":[17,193],"resection.":[18,194],"Evidence":[19],"supporting":[20],"the":[21,81],"efficacy":[22,63,155],"of":[23,66,99,109,111,139,148,154,156],"combined":[24,200],"VEGF":[25,201],"and":[26,64,102,124,202],"PD-1":[27],"inhibition":[28,204],"in":[29,41,68,73],"other":[30],"tumor":[31],"types":[32],"provided":[33],"a":[34,56,122,152,161],"compelling":[35],"rationale":[36],"investigating":[38],"this":[39],"combination":[40,83],"AA,":[42],"where":[43],"immune":[44],"checkpoint":[45],"inhibitors":[46],"have":[47],"not":[48,190],"been":[49],"explored":[50],"previously.":[51],"Experimental":[52],"Design:":[53],"We":[54],"conducted":[55],"prospective,":[57],"single-arm":[58],"phase":[59],"II":[60],"study":[61,172],"evaluating":[62],"safety":[65],"atezolizumab":[67],"conjunction":[69],"bevacizumab":[71],"(Atezo+Bev)":[72],"advanced,":[74],"unresectable":[75,169],"AA.":[76],"Results:":[77],"Patients":[78],"treated":[79,130],"Atezo+Bev":[82,159],"had":[84],"100%":[85],"control":[87,128],"rate":[88],"(1":[89],"partial":[90],"response,":[91],"15":[92],"stable":[93],"disease)":[94],"progression-free":[96],"survival":[97,104,115],"(PFS)":[98],"18.3":[100],"months":[101],"overall":[103],"not-yet-reached":[105],"median":[107],"duration":[108],"follow-up":[110],"40":[112],"months.":[113],"These":[114,195],"intervals":[116],"were":[117],"significantly":[118],"longer":[119],"relative":[120],"clinically":[123],"molecularly":[125],"matched":[126],"synthetic":[127],"cohort":[129],"cytotoxic":[132],"chemotherapy":[133],"designed":[134],"colorectal":[136],"cancer":[137],"(PFS":[138],"4.4":[140],"months,":[141],"P":[142],"=":[143],"0.041).":[144],"Conclusions:":[145],"In":[146],"light":[147],"recent":[149],"data":[150,196],"demonstrating":[151],"lack":[153],"5-fluorouracil\u2013based":[157],"chemotherapy,":[158],"is":[160,173],"promising":[162],"option":[164],"low-grade":[168],"AA;":[170],"further":[171,207],"warranted.":[174],"Significance:":[175],"AA":[176],"systemic":[183],"therapy":[184],"who":[188],"are":[189],"candidates":[191],"suggest":[197],"activity":[198],"from":[199],"PD-L1":[203],"that":[205],"warrants":[206],"study.":[208]},"counts_by_year":[],"updated_date":"2026-09-24T07:57:37.273135","created_date":"2025-10-10T00:00:00"}